{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:14:43Z","timestamp":1723043683102},"reference-count":35,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>ABSTRACT  Background:  Obesity is an epidemic and chronic disease that can bring other comorbidities to the patient. Non-alcoholic fatty liver disease is present in up to 90% of these patients and can progress to hepatitis and hepatocarcinoma. The relationship of this liver disease and obesity is already well known; however, it is possible that some parameters of the comorbidities are more related than others in the pathophysiology of the disease.  Aim:  Was analyzed the relationship between non-alcoholic fatty liver disease (NAFLD) and the comorbidities of metabolic syndrome in morbidly obese patients.  Methods:  Was involved ultrasonography and laboratory assessment of obese patients before bariatric surgery. NAFLD was assessed using the same sonography parameters for all patients. Based on the results, the patients were divided into groups with and without NAFLD. Comparisons between them involved clinical and laboratory variables such as fasting blood glucose, insulin, HOMA-IR (homeostasis model assessment - insulin resistance), glycated hemoglobin, total cholesterol and fractions, triglycerides, alanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase, C-reactive protein, albumin and ferritin. Patients who reported alcohol abuse (defined as the consumption of &gt;14 drinks per week) or who had hepatitis were excluded.  Results:  Eighty-two patients (74 women and 8 men) were studied, of whom 53 (64.6%) had NAFLD and 29 (35.4%) did not. The levels of glycated hemoglobin (p=0.05) and LDL cholesterol (p=0.01) were significantly altered in patients with NAFLD. However, weight, body mass index and excess weight did not differ significantly between the groups (p=0.835, p=0.488 and p=0.727, respectively).  Conclusions:  Altered LDL cholesterol and glycated hemoglobin levels were related to the presence of NAFLD.<\/jats:p>","DOI":"10.1590\/0102-6720201600040011","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T21:24:09Z","timestamp":1483824249000},"page":"260-263","source":"Crossref","is-referenced-by-count":4,"title":["CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY"],"prefix":"10.1590","volume":"29","author":[{"given":"Fernando de","family":"BARROS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Andarai Federal Hospital,  Brazil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"SET\u00daBAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manoel","family":"MARTINHO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loraine","family":"FERRAZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa","family":"GAUD\u00caNCIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"FIOCRUZ,  Brazil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Fluminense Federal University,  Brazil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Fluminense Federal University,  Brazil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease a population-based cohort study","volume":"129","author":"Adams LA","year":"2005","journal-title":"Gastroenterology"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1038\/ajg.2010.275","article-title":"Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in non-diabetic subjects","volume":"105","author":"Bae JC","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"ref3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","article-title":"Ultrasonographic fatty liver indicator a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD","volume":"32","author":"Ballestri S1","year":"2012","journal-title":"Liver Int"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell SH","year":"1999","journal-title":"Hepatology"},{"year":"2004","series-title":"National Health and Nutrition Examination Survey","key":"ref5"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequence and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton MR","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis AP","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref8","first-page":"31","article-title":"Obesity prevalence and metabolic syndrome in a park users","volume":"28","author":"de Souza MDG","year":"2015","journal-title":"Arq Bras Cir Dig"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel RH","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag HB","year":"2004","journal-title":"Gastroenterology"},{"year":"2005","series-title":"The Obesity Epidemic: Science, Morality and Ideology","author":"Gard M","key":"ref11"},{"issue":"8","key":"ref12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","article-title":"Non-alcoholic steatohepatitis in type 2 diabetes mellitus","volume":"19","author":"Gupte P","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"ref13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s00535-010-0203-y","article-title":"Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia clinical usefulness of AGEs as a biomarker for the attenuation of NASH","volume":"45","author":"Kimura Y","year":"2010","journal-title":"J Gastroenterol"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2012.12.026","article-title":"Bariatric surgery for curing NASH in the morbidly obese","volume":"58","author":"Lassailly G","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite NC","year":"2009","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/BF01738018","article-title":"Der konstitutionsindex der frau","volume":"16","author":"Lorentz FH","year":"1929","journal-title":"Klin Wochenshr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease a feature of the metabolic syndrome","volume":"50","author":"Marchesini G","year":"2001","journal-title":"Diabetes"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"ref19","first-page":"17","article-title":"Diabetes mellitus, obesity, and hepatic steatosis","volume":"13","author":"McCullough AJ","year":"2002","journal-title":"Semin Gastrointes Dis"},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0030-1267541","article-title":"Current status and future of liver transplantation","volume":"30","author":"Merion RM","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"8","key":"ref21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso D","year":"2011","journal-title":"Ann Med"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00592-008-0067-2","article-title":"The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"46","author":"Nar A","year":"2009","journal-title":"Acta Diabetol"},{"issue":"3","key":"ref23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients","volume":"15","author":"Ong JP","year":"2005","journal-title":"Obes Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12665","article-title":"A Single Non-invasive Model to Diagnose Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).","author":"Otgonsuren M","year":"2014","journal-title":"Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"ref25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1590\/S0102-6720201400S100021","article-title":"Bariatric surhery (sleeve gastrectomy) after liver transplantation case report","volume":"27","author":"Pajecki D","year":"2014","journal-title":"Arq Bras Cir Dig"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0102-6720201400S100001","article-title":"Brazil looking for completing his space in bariatric surgery","volume":"27","author":"Ramos AC","year":"2014","journal-title":"Arq bras Cir Dig"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes","volume":"370","author":"Schauer PR","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"ref28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrendo.2011.72","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus pathogenesis and treatment","volume":"7","author":"Smith BW","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza MR","year":"2012","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/dia.2013.0165","article-title":"Comparison of characteristics between nonobese and overweight\/obesesubjects with nonalcoholic fatty liver disease in a South Indian population","volume":"16","author":"Vendhan R","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"ref31","first-page":"306748","article-title":"Non-alcoholic fatty liver disease: roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis","author":"Verbeek J","year":"2014","journal-title":"Gut gutjnl"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0034-1371549","article-title":"Liver biopsy at the time of bariatric surgery a benefit for patients and the medical community","volume":"34","author":"Verna EC","year":"2014","journal-title":"Semin Liver Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee SG","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic ef cacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama S","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"ref35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi ZM","year":"2012","journal-title":"Medicine (Baltimore)"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abcd\/v29n4\/0102-6720-abcd-29-04-00260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T20:25:45Z","timestamp":1493411145000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202016000400260&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0102-67202016000400260"],"URL":"https:\/\/doi.org\/10.1590\/0102-6720201600040011","relation":{},"ISSN":["0102-6720"],"issn-type":[{"type":"electronic","value":"0102-6720"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}